HealthCare

Home > HealthCare
  • All
  • Company Report
  • company reports
  • Industry Report
March 17, 2020

Abbott and Insulet Corporation , the global leader in tubeless insulin pump technology with its  mnipod® Insulin Management System (Omnipod System), announced today they are partnering to integrate Abbott’s world-leading1 glucose sensing technology with Insulet’s next-generation tubeless system, the Omnipod Horizon™ Automated Insulin Delivery (AID) System (Omnipod Horizon System), to offer personalized automated insulin delivery […]

Read more
March 16, 2020

J&J has strong pipeline of products which will continue to deliver growing sales to keep revenue from its pharmaceuticals segment afloat. Some of the company’s current products are also seeking additional indications. Imbruvica is currently in phase 3 testing for the treatment of mantle cell lymphoma, and Tremfya is in phase 3 testing for the […]

Read more
March 16, 2020

TMO  significantly strengthened its pharma services network in 2019 by acquiring leading viral vector manufacturer Brammer Bio and the GSK active pharmaceutical ingredient manufacturing site in Ireland and expanding production capacity at facilities in North America and Europe to support growing demand for biologics and gene therapies.  Executive Summary Financial Statements – Income Statement and […]

Read more
March 4, 2020

Novartis’s key growth drivers were mainly Cosentyx,Entresto and Zolgensma for the Pharmaceuticals Business Unit and Promacta/Revolade, Kisqali and Lutathera for the Oncology Business Unit.The company acquired “The Medicines Company”, adding inclisiran a potentially transformative cholesterol-lowering therapy. NVS also acquired Xiidra, strengthening ophthalmic pharmaceuticals portfolio. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet […]

Read more
February 27, 2020

Anthem successfully completed the IngenioRx migration, transitioning more than 15mn people over the past 8 months. The launch of IngenioRx is a key milestone for the growth of the company as they expect huge revenues growth in coming quarters. Executive Summary  Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow – […]

Read more
February 25, 2020

Biogen recently won a patent challenge to its billion-dollar MS drug, Tecfidera. Unless an appeal by Mylan or other ongoing patent challenges results in a different ruling, this means that the company can stave off Tecfidera competition until patent expiration in 2028. It presented detailed results from the Phase 3 EVOLVE-MS-2 study of VUMERITY (diroximel […]

Read more
February 24, 2020

UnitedHealthcare Medicare & Retirement revenues grew by 10.3% to $83.3bn in 2019, as the business grew to serve 5.3mn people in Medicare Advantage at year end, an increase of 325,000 in 2019. Medicare Advantage growth was diversified, reflecting strong performance in both the individual and group retiree markets. • Executive Summary • Financial Statements – […]

Read more
February 14, 2020

BHC delivered another strong quarter with both reported and organic revenue growth due to growth in its segments. In addition to organic revenue growth in both the Bausch +Lomb/International and Salix segments, due to higher revenues in several of durable, established brands, such as XIFAXAN®, BioTrue® ONEday and Bausch + Lomb ULTRA®, performance was also […]

Read more
December 2, 2019

The U.S. economy grew by 1.9% in Q3FY19. There was a dip in net exports, private, fixed investments and inventories which weighed on the growth, but the consumer spending stabilized the American economy. The consumer confidence plummeted in August, post the fresh escalations to the U.S.- China trade war. There was a contraction in the […]

Read more
November 28, 2019

Impact investing is an exciting and rapidly growing industry powered by investors who are determined to generate social and environmental impact as well as financial returns. This is taking place all over the world, and across all asset classes. Table of Contents Executive Summary Overview Industry Analysis Result Based Financing Green Bonds Trends in 2019 […]

Read more
August 16, 2019

Total revenues for the quarter increased by 8% to $1.39bn. This increase was due to ongoing demand from new and existing clients. Bookings decreased by 11% to $1.24bn due to decline in long term contracts. Operating cash flow were $317mn in Q1FY19. Free cash flow decreased by $132mn due to decrease in cash from operations […]

Read more
August 7, 2019

Anthem reported significant growth in the risk-based membership and improved the penetration of the clinical and specialty services. The operating revenues increased by $2,129mn to $24,666mn in Q1FY19 compared to $22,537mn in Q1FY18. The increase in operating revenues was due to membership growth and rate increases. Number of Slides – 38 Contents Executive Summary Financial […]

Read more
July 29, 2019

Worldwide sales for Merck increased by 8% to $10.8bn in Q1FY19, excluding the negative impact from foreign exchange, sales grew 11%, driven by growth in Oncology and Vaccines. GAAP EPS were $1.12 for the quarter and non-GAAP EPS increased by 16% to $1.22 for the quarter. Number of Pages – 43 Contents Executive Summary Financial […]

Read more
June 27, 2019

Pfizer’s revenues increased by 1.6% to $13.1bn in Q1FY19, which reflects operational growth of 5% and the unfavorable impact of foreign exchange of 4%. GAAP EPS increased by 15% to $0.68 in Q1FY19. Number of Pages – 56 Contents Executive Summary Financial Statements –Income Statement and Forecast –Balance Sheet –Cash Flow –Q1FY19 Results – Overview […]

Read more
June 14, 2019

Novartis revenues grew by 2% to $11.1bn in Q1FY19 with the Mayzent launch, successful Alcon spin-off, and strong operational execution. Core operating income grew at 18% and core margin expanding by 2.6% during the quarter. Net income grew by 4% due to the impact of a net impairment charge and lower divestment gains. Number of […]

Read more
June 11, 2019

Bausch Health is off to a strong start in 2019 with the continued growth of XIFAXAN® which grew 11% in the quarter, the launch of BRYHALI™, the successful acquisition of TRULANCE®, and the approval of DUOBRII™ and expected a launch in June. Number of Pages – 47 Contents Executive Summary Financial Statements –Income Statement and […]

Read more
June 11, 2019

UnitedHealth Group’s revenues grew by 9.3% to $60.3bn in Q1FY19 led by UnitedHealthcare Medicare & Retirement, OptumRx and OptumHealth. Number of Pages – 39 Contents Executive Summary Financial Statements –Income Statement and Forecast –Balance Sheet –Cash Flow –Q1FY19 Results – Overview –Q1FY19 – Segment Performance –FY19 – Guidance and Conclusion –GAAP to Non-GAAP Reconciliation Historical […]

Read more
June 11, 2019

JNJ’s sales grew by 0.1% to $20bn in Q1FY19 with 3.9% operational growth and 5.5% adjusted operational sales growth. Adjusted EPS increased by 1.9% to $2.1 and GAAP EPS decreased by 13.1% to $1.39 Number of Pages – 54 Contents: Executive Summary Financial Statements –  Income Statement and Forecast –  Balance Sheet –  Cash Flow […]

Read more
March 11, 2019

Global Healthcare IT Market is expected to grow to USD 340.9 Bn in 2024, from USD 131bn in 2016 and, growing at a CAGR of 12.5% during the forecast period 2017 to 2024.

Read more
Load more